Do You See What I See?
December 08, 2013 – Emily Morrison
Pancreatic Cancer Advocates Unite
December 08, 2013 – Julie Fleshman
Pipeline
December 09, 2013 – Lindsay Ray
The Challenges of Distance Caregiving
December 09, 2013 – Jane Hill
Adult Siblings Often Coordinate Parental Support
December 09, 2013 – Jane Hill
What Could Cause Cognitive Dysfunction after Cancer?
December 09, 2013 – Kathy LaTour
Pharmacologic Approaches to Cognitive Dysfunction
December 09, 2013 – Kathy LaTour
Finding Solutions for Chemobrain
December 08, 2013 – Kathy LaTour
Post-Traumatic Stress Disorder after Childhood Cancer
December 09, 2013 – Don Vaughan
Late Effects & Premature Aging After Pediatric Cancer
December 09, 2013 – Don Vaughan
Health Problems Common in Survivors of Pediatric Cancer
December 09, 2013 – Don Vaughan
Post-Mastectomy Pain Hits a Nerve
December 09, 2013 – Lacey Marlow
Advances in Screening & Early Detection of Pancreatic Cancer
December 09, 2013 – Roxanne Nelson
Changing Course in Pancreatic Cancer
December 09, 2013 – Roxanne Nelson
Tumor Evolution
December 08, 2013 – Katy Human
Solving the Treatment Resistance Riddle
December 09, 2013 – Katy Human
For Caregivers: Tips Before Planning that "End of Treatment" Party
December 09, 2013 – Charlotte Huff
Why Observing Treatment Milestones is an Individual Decision
December 09, 2013 – Charlotte Huff
Searching for an Oncology Surgeon
December 08, 2013 – Katherine Hobson
Is Robot-Assisted Surgery the Best Treatment for Your Cancer?
December 08, 2013 – Katherine Hobson
How I Lost My Uterus and Found My Voice
December 09, 2013 – Kathy LaTour
Personalized Medicine Should Include High-Quality, High-Value Care
December 09, 2013 – Len Lichtenfeld, MD
Website Retooled to Help Visitors Navigate Medicare
December 08, 2013 – Jon Garinn
Poor Kidney Function a Possibility in Adult Survivors of Childhood Cancer
December 09, 2013 – Katherine Lagomarsino
Dispatch: Society for Integrative Oncology's 10th Annual Meeting
December 09, 2013 – Debu Tripathy, MD
Reel Recovery Retreats
December 09, 2013 – Jon Garinn
Studies Confirm Effectiveness of Colorectal Cancer Screening
December 09, 2013 – Elizabeth Whittington
Michael Douglas Reveals He Had Tongue Cancer
December 09, 2013 – Lindsay Ray
Dose of Reality Effective at Stopping Smokers
December 09, 2013 – Lena Huang
FDA's Breakthrough Therapy Designation Aims to Speed Drug Approvals
December 08, 2013 – Susan Jenks
ASH Updates
December 08, 2013 – Elizabeth Whittington
Message From the Editor
December 09, 2013 – Debu Tripathy, MD
Letters From Readers
December 08, 2013
Do You See What I See?
December 08, 2013 – Emily Morrison
Currently Viewing
Pancreatic Cancer Advocates Unite
December 08, 2013 – Julie Fleshman
The Challenges of Distance Caregiving
December 09, 2013 – Jane Hill
Adult Siblings Often Coordinate Parental Support
December 09, 2013 – Jane Hill
What Could Cause Cognitive Dysfunction after Cancer?
December 09, 2013 – Kathy LaTour
Pharmacologic Approaches to Cognitive Dysfunction
December 09, 2013 – Kathy LaTour
Finding Solutions for Chemobrain
December 08, 2013 – Kathy LaTour
Post-Traumatic Stress Disorder after Childhood Cancer
December 09, 2013 – Don Vaughan
Late Effects & Premature Aging After Pediatric Cancer
December 09, 2013 – Don Vaughan
Health Problems Common in Survivors of Pediatric Cancer
December 09, 2013 – Don Vaughan
Post-Mastectomy Pain Hits a Nerve
December 09, 2013 – Lacey Marlow
Advances in Screening & Early Detection of Pancreatic Cancer
December 09, 2013 – Roxanne Nelson
Changing Course in Pancreatic Cancer
December 09, 2013 – Roxanne Nelson
Tumor Evolution
December 08, 2013 – Katy Human
Solving the Treatment Resistance Riddle
December 09, 2013 – Katy Human
For Caregivers: Tips Before Planning that "End of Treatment" Party
December 09, 2013 – Charlotte Huff
Why Observing Treatment Milestones is an Individual Decision
December 09, 2013 – Charlotte Huff
Searching for an Oncology Surgeon
December 08, 2013 – Katherine Hobson
Is Robot-Assisted Surgery the Best Treatment for Your Cancer?
December 08, 2013 – Katherine Hobson
How I Lost My Uterus and Found My Voice
December 09, 2013 – Kathy LaTour
Personalized Medicine Should Include High-Quality, High-Value Care
December 09, 2013 – Len Lichtenfeld, MD
Website Retooled to Help Visitors Navigate Medicare
December 08, 2013 – Jon Garinn
Poor Kidney Function a Possibility in Adult Survivors of Childhood Cancer
December 09, 2013 – Katherine Lagomarsino
Dispatch: Society for Integrative Oncology's 10th Annual Meeting
December 09, 2013 – Debu Tripathy, MD
Reel Recovery Retreats
December 09, 2013 – Jon Garinn
Studies Confirm Effectiveness of Colorectal Cancer Screening
December 09, 2013 – Elizabeth Whittington
Michael Douglas Reveals He Had Tongue Cancer
December 09, 2013 – Lindsay Ray
Dose of Reality Effective at Stopping Smokers
December 09, 2013 – Lena Huang
FDA's Breakthrough Therapy Designation Aims to Speed Drug Approvals
December 08, 2013 – Susan Jenks
ASH Updates
December 08, 2013 – Elizabeth Whittington
Message From the Editor
December 09, 2013 – Debu Tripathy, MD
Letters From Readers
December 08, 2013
Whole Foods Help Against Cancer
December 07, 2013 – Jeanne Erdmann

Pancreatic Cancer Advocates Unite

When advocates unite, they can move a nation to act.

BY Julie Fleshman
PUBLISHED December 08, 2013

When my father received a diagnosis of pancreatic cancer in 1999 at the age of 52, he was given few options for treatment and was told to go home and get his affairs in order. He died four months later. I was angry that I had nowhere to turn for answers and that nothing was actively being done to change patient outcomes. I wanted the opportunity to speak out against this devastating disease. Since then, a pancreatic cancer advocacy movement has gained steady momentum and is helping to transform the pancreatic cancer community.

The Pancreatic Cancer Action Network is playing an important role in this movement by bringing people together—individuals like me who have been personally touched by pancreatic cancer—and giving us a voice. Just more than a decade ago, there was no coordinated pancreatic cancer scientific community. There was just a handful of dedicated scientists working in the field. Today, more scientists are studying pancreatic cancer and building the foundation of knowledge necessary to improve patient outcomes. The field is reaching a tipping point, and now, more than ever, we have to continue to invest in the foundation that has been built. This investment must include both federal and private research dollars, and it must ensure that patients are aware of cutting-edge science, including clinical trials that will help advance treatment options for the disease.

Our personal stories made a difference and, when spoken together, had strength, power and purpose.

I will never forget the day six years ago when I met with U.S. Rep. Anna Eshoo of California in her Washington, D.C., office to discuss the lack of research efforts dedicated to pancreatic cancer. She was extremely enthusiastic about doing something to put a greater focus on the disease. But what I remember most was her wise advice: “We can’t do this alone,” she said. She reinforced that, in order to make a difference, we had to activate advocates from across the country to create a sense of urgency about pancreatic cancer and tell our personal stories.

And that is exactly what we set out to do. This army of patients, families and friends from across the country were emboldened by the challenge they faced. They wrote to their members of Congress, traveled to Washington, D.C., and went above and beyond in hopes of making a difference in honor of loved ones, for themselves and for future generations. Like Randy Pausch, the Carnegie Mellon professor and author of The Last Lecture, who testified before Congress just months before he died from pancreatic cancer. Like Lisa Niemi, who traveled to Capitol Hill several times in honor of her late husband, Patrick Swayze. Like Jill Ward, an active 54-year-old mother of three, who was told that she had tried the last treatment option available to her, but still met with her congressional representatives because she knew it would help those who came after her.

Our voices were heard by Congress, and a significant milestone was achieved in January 2013 when President Barack Obama signed the Recalcitrant Cancer Research Act, formerly known as the Pancreatic Cancer Research and Education Act, into law. The bill’s passage was a true testament to the passion and dedication of the patients, families and volunteers who wouldn’t take no for an answer.

Our personal stories made a difference and, when spoken together, had strength, power and purpose. But our work is far from over. Progress requires the continued dedication of passionate advocates, volunteers and supporters. I am lucky to work with these courageous individuals in honor and in memory of the heroes in their lives.

Julie Fleshman is the President and CEO of the Pancreatic Cancer Action Network.

Be the first to discuss this article on CURE's forum. >>
Talk about this article with other patients, caregivers, and advocates in the Pancreatic Cancer CURE discussion group.

Related Articles

1
×

Sign In

Not a member? Sign up now!
×

Sign Up

Are you a member? Please Log In